Aixin Li
Impact in
- Immunology top 10%
- interferon and immune responses
- Infectious Diseases top 5%
- Viral Infections and Vectors
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- Viral Infections and Vectors 4
-
- interferon and immune responses 6
- Journals
- Journal of Virology (3 papers)Chemical Engineering Journal (2 papers)Nano Letters (2 papers)Virulence (2 papers)PLoS Pathogens (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Aixin Li
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 140
- Immunology 297
- Infectious Diseases 244
- Molecular Biology 670
- Biological Psychiatry 17
- Cancer Research 89
Countries citing papers authored by Aixin Li
This map shows the geographic impact of Aixin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aixin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aixin Li more than expected).
Fields of papers citing papers by Aixin Li
This network shows the impact of papers produced by Aixin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aixin Li. The network helps show where Aixin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aixin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 20 | |
| 6 | 2023 | 58 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 24 | |
| 9 | 2022 | 56 | |
| 10 | 2022 | 12 | |
| 11 | 2022 | 14 | |
| 12 | 2022 | 77 | |
| 13 | 2022 | 10 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 63 | |
| 16 | 2020 | 172 | |
| 17 | 2018 | 66 | |
| 18 | 2018 | 162 | |
| 19 | 2017 | 19 | |
| 20 | 2009 | 218 |
About Aixin Li
Aixin Li is a scholar working on Infectious Diseases, Immunology, Molecular Biology, Epidemiology and Hepatology, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), interferon and immune responses (6 papers), Hepatitis B Virus Studies (6 papers), Mosquito-borne diseases and control (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Advanced Nanomaterials in Catalysis (4 papers) and Viral Infections and Vectors (4 papers). The work is most often cited by research in Immunology (297 citations), Infectious Diseases (244 citations), Molecular Biology (670 citations), Biological Psychiatry (17 citations) and Cancer Research (89 citations). Aixin Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jianguo Wu, Wenbiao Wang, Yingchong Wang, Feng Xiao, Mingfu Tian, Yingle Liu, Pan Pan, Kailang Wu, Pin Wan and Dingwen Hu. Their work appears in journals such as Journal of Virology, Chemical Engineering Journal, Nano Letters, Virulence and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.